K
Kelly T. McKee
Researcher at United States Department of the Army
Publications - 15
Citations - 972
Kelly T. McKee is an academic researcher from United States Department of the Army. The author has contributed to research in topics: Junin virus & Argentine hemorrhagic fever. The author has an hindex of 13, co-authored 15 publications receiving 955 citations.
Papers
More filters
Book ChapterDOI
Experimental Studies of Arenaviral Hemorrhagic Fevers
C. J. Peters,Peter B. Jahrling,Ching-Tong Liu,Richard H. Kenyon,Kelly T. McKee,J. G. Barrera Oro +5 more
TL;DR: Three arenaviruses, Lassa, Junin, and Machupo, regularly cause serious disease when they infect humans and there is increasing acceptance that they share sufficient, common, clinical and pathophysiological findings to refer to a viral hemorrhagic (HF) syndrome.
Journal ArticleDOI
Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory
Nancy K. Jaax,Peter B. Jahrling,Thomas W. Geisbert,Joan B. Geisbert,Keith E. Steele,Kelly T. McKee,D. Nagley,E. D. Johnson,G. Jaax,C. J. Peters +9 more
TL;DR: Transmission of Ebola virus to two of three control rhesus monkeys that did not have direct contact with experimentally inoculated monkeys held in the same room is reported to suggest approaches to the study of routes of transmission to and among humans.
Journal ArticleDOI
High-Dose Dexamethasone in Quinine-Treated Patients with Cerebral Malaria: A Double-Blind, Placebo-Controlled Trial
Stephen L. Hoffman,Diet Rustama,Narain H. Punjabi,Binsar Surampaet,Bernardus Sanjaya,Anthony J. Dimpudus,Kelly T. McKee,Fred P. Paleologo,James R. Campbell,H. Marwoto,Larry W. Laughlin +10 more
TL;DR: It is concluded that high-dose dexamethasone is not indicated for treating cerebral malaria, and patients in each group were comparable on admission, and four patients died.
Journal ArticleDOI
Cold-Adapted Recombinant Influenza A Virus Vaccines in Seronegative Young Children
TL;DR: Two live, attenuated, intranasally administered influenza virus vaccines were evaluated in 21 seronegative young children at Vanderbilt Children's Hospital and children previously vaccinated with the related strain, influenza A/Alaska (H3N2) virus, were significantly protected as judged by serologic evidence of reinfection.
Journal ArticleDOI
Ribavirin Therapy for Hantaan Virus Infection in Suckling Mice
TL;DR: After ribavirin treatment, titers of virus decreased in serum, liver, and spleen by two days; in lung within six days; and in the kidney by eight days, with the exception of the brain, which fell 100-fold lower than in sham-treated animals.